申请人:Yamada Rintaro
公开号:US20100093789A1
公开(公告)日:2010-04-15
A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G
1
represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G
2
represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G
3
represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G
4
represents hydroxyl group, or —N(R
1
)(R
2
) (R
1
and R
2
represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, or a saturated heterocyclic group); G
5
is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.
化合物由以下公式表示(1) [A代表含
氮饱和环;m表示0到2的整数;n表示1到4的整数;G1代表
氢原子、
氯原子、羟基、烷
氧基或
氨基;G2代表卤原子、羟基、
氰基、羧基、烷基、
烯基等;G3代表
氢原子、卤原子、羟基、
氰基、羧基、烷基、
烯基等;G4代表羟基,或-N(R1)(R2) (R1和R2代表
氢原子、烷基、芳基烷基、
烯基、炔基或饱和杂环基);G5是A的环构成
碳原子上的取代基,代表
氢原子、
氟原子或烷基]或其盐,或其作为前药的衍
生物,强力抑制Rho激酶。